| References: |
1. Davis, M. M., J. J. Boniface, Z. Reich, D. Lyons, J. Hampl, B. Arden, and
Y. Chien. 1998. Ligand recognition by alpha beta T cell receptors. Annu. Rev.
Immunol. 16: 523–544.
2. Rudolph, M. G., and I. A. Wilson. 2002. The specificity of TCR/pMHC interaction.
Curr. Opin. Immunol. 14: 52–65.
3. Rudolph, M. G., R. L. Stanfield, and I. A. Wilson. 2006. How TCRs bind MHCs,
peptides, and coreceptors. Annu. Rev. Immunol. 24: 419–466.
4. Arstila, T. P., A. Casrouge, V. Baron, J. Even, J. Kanellopoulos, and P. Kourilsky.
1999. A direct estimate of the human alphabeta T cell receptor diversity. Science
286: 958–961.
5. Mason, D. 1998. A very high level of crossreactivity is an essential feature of the
T-cell receptor. Immunol. Today 19: 395–404.
6. Wilson, D. B., D. H. Wilson, K. Schroder, C. Pinilla, S. Blondelle,
R. A. Houghten, and K. C. Garcia. 2004. Specificity and degeneracy of T cells.
Mol. Immunol. 40: 1047–1055.
7. Gao, G. F., J. Tormo, U. C. Gerth, J. R. Wyer, A. J. McMichael, D. I. Stuart,
J. I. Bell, E. Y. Jones, and B. K. Jakobsen. 1997. Crystal structure of the complex
between human CD8alpha(alpha) and HLA-A2. Nature 387: 630–634.
8. Wang, R., K. Natarajan, and D. H. Margulies. 2009. Structural basis of the CD8
alpha beta/MHC class I interaction: focused recognition orients CD8 beta to
a T cell proximal position. J. Immunol. 183: 2554–2564.
9. Zamoyska, R. 1998. CD4 and CD8: modulators of T-cell receptor recognition of
antigen and of immune responses? Curr. Opin. Immunol. 10: 82–87.
10. Zamoyska, R., P. Derham, S. D. Gorman, P. von Hoegen, J. B. Bolen,
A. Veillette, and J. R. Parnes. 1989. Inability of CD8 alpha9 polypeptides to
associate with p56lck correlates with impaired function in vitro and lack of
expression in vivo. Nature 342: 278–281.
11. Arcaro, A., C. Gre´goire, T. R. Bakker, L. Baldi, M. Jordan, L. Goffin,
N. Boucheron, F. Wurm, P. A. van der Merwe, B. Malissen, and I. F. Luescher.
2001. CD8beta endows CD8 with efficient coreceptor function by coupling
T cell receptor/CD3 to raft-associated CD8/p56lck complexes. J. Exp. Med. 194:
1485–1495.
12. Veillette, A., M. A. Bookman, E. M. Horak, and J. B. Bolen. 1988. The CD4 and
CD8 T cell surface antigens are associated with the internal membrane tyrosineprotein
kinase p56lck. Cell 55: 301–308.
13. Purbhoo, M. A., J. M. Boulter, D. A. Price, A. L. Vuidepot, C. S. Hourigan,
P. R. Dunbar, K. Olson, S. J. Dawson, R. E. Phillips, B. K. Jakobsen, et al. 2001.
The human CD8 coreceptor effects cytotoxic T cell activation and antigen
sensitivity primarily by mediating complete phosphorylation of the T cell receptor
zeta chain. J. Biol. Chem. 276: 32786–32792.
14. Luescher, I. F., E. Vivier, A. Layer, J. Mahiou, F. Godeau, B. Malissen, and
P. Romero. 1995. CD8 modulation of T-cell antigen receptor-ligand interactions
on living cytotoxic T lymphocytes. Nature 373: 353–356.
15. Wooldridge, L., H. A. van den Berg, M. Glick, E. Gostick, B. Laugel,
S. L. Hutchinson, A. Milicic, J. M. Brenchley, D. C. Douek, D. A. Price, and
A. K. Sewell. 2005. Interaction between the CD8 coreceptor and major histocompatibility
complex class I stabilizes T cell receptor-antigen complexes at
the cell surface. J. Biol. Chem. 280: 27491–27501.
16. Rabinowitz, J. D., C. Beeson, D. S. Lyons, M. M. Davis, and H. M. McConnell.
1996. Kinetic discrimination in T-cell activation. Proc. Natl. Acad. Sci. USA 93:
1401–1405.
17. Kersh, G. J., E. N. Kersh, D. H. Fremont, and P. M. Allen. 1998. High- and lowpotency
ligands with similar affinities for the TCR: the importance of kinetics in
TCR signaling. Immunity 9: 817–826.
18. van den Berg, H. A., and D. A. Rand. 2007. Quantitative theories of
T-cell responsiveness. Immunol. Rev. 216: 81–92.
19. Aleksic, M., O. Dushek, H. Zhang, E. Shenderov, J. L. Chen, V. Cerundolo,
D. Coombs, and P. A. van der Merwe. 2010. Dependence of T cell antigen recognition
on T cell receptor-peptide MHC confinement time. Immunity 32: 163–174.
20. Laugel, B., H. A. van den Berg, E. Gostick, D. K. Cole, L.Wooldridge, J. Boulter,
A. Milicic, D. A. Price, and A. K. Sewell. 2007. Different T cell receptor affinity
thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation
and tetramer binding properties. J. Biol. Chem. 282: 23799–23810.
21. van den Berg, H. A., L. Wooldridge, B. Laugel, and A. K. Sewell. 2007. Coreceptor
CD8-driven modulation of T cell antigen receptor specificity. J. Theor.
Biol. 249: 395–408.
22. Gakamsky, D. M., I. F. Luescher, A. Pramanik, R. B. Kopito, F. Lemonnier,
H. Vogel, R. Rigler, and I. Pecht. 2005. CD8 kinetically promotes ligand binding
to the T-cell antigen receptor. Biophys. J. 89: 2121–2133.
23. Holler, P. D., and D. M. Kranz. 2003. Quantitative analysis of the contribution of
TCR/pepMHC affinity and CD8 to T cell activation. Immunity 18: 255–264.
24. Yachi, P. P., J. Ampudia, T. Zal, and N. R. Gascoigne. 2006. Altered peptide
ligands induce delayed CD8-T cell receptor interaction: a role for CD8 in distinguishing
antigen quality. Immunity 25: 203–211.
25. Zal, T., M. A. Zal, and N. R. Gascoigne. 2002. Inhibition of T cell receptorcoreceptor
interactions by antagonist ligands visualized by live FRET imaging of
the T-hybridoma immunological synapse. Immunity 16: 521–534.
26. Wooldridge, L., A. Lissina, J. Vernazza, E. Gostick, B. Laugel, S. L. Hutchinson,
F. Mirza, P. R. Dunbar, J. M. Boulter, M. Glick, et al. 2007. Enhanced immunogenicity
of CTL antigens through mutation of the CD8 binding MHC class I
invariant region. Eur. J. Immunol. 37: 1323–1333.
27. Kan-Mitchell, J., M. Bajcz, K. L. Schaubert, D. A. Price, J. M. Brenchley,
T. E. Asher, D. C. Douek, H. L. Ng, O. O. Yang, C. R. Rinaldo, Jr., et al. 2006.
Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response.
J. Immunol. 176: 6690–6701.
28. Betts, M. R., J. M. Brenchley, D. A. Price, S. C. De Rosa, D. C. Douek,
M. Roederer, and R. A. Koup. 2003. Sensitive and viable identification of
antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J.
Immunol. Methods 281: 65–78.
29. Purbhoo, M. A., Y. Li, D. H. Sutton, J. E. Brewer, E. Gostick, G. Bossi,
B. Laugel, R. Moysey, E. Baston, N. Liddy, et al. 2007. The HLA A*0201-restricted
hTERT(540-548) peptide is not detected on tumor cells by a CTL clone
or a high-affinity T-cell receptor. Mol. Cancer Ther. 6: 2081–2091.
30. Madrenas, J., L. A. Chau, J. Smith, J. A. Bluestone, and R. N. Germain. 1997.
The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/
partial agonist properties of peptide-MHC molecule ligands. J. Exp. Med. 185:
219–229.
31. Daniels, M. A., and S. C. Jameson. 2000. Critical role for CD8 in T cell receptor
binding and activation by peptide/major histocompatibility complex multimers.
J. Exp. Med. 191: 335–346.
32. Kerry, S. E., J. Buslepp, L. A. Cramer, R. Maile, L. L. Hensley, A. I. Nielsen,
P. Kavathas, B. J. Vilen, E. J. Collins, and J. A. Frelinger. 2003. Interplay between
TCR affinity and necessity of coreceptor ligation: high-affinity peptide-
MHC/TCR interaction overcomes lack of CD8 engagement. J. Immunol. 171:
4493–4503.
33. Wooldridge, L., M. Clement, A. Lissina, E. S. Edwards, K. Ladell, J. Ekeruche,
R. E. Hewitt, B. Laugel, E. Gostick, D. K. Cole, et al. 2010. MHC class I
molecules with superenhanced CD8 binding properties bypass the requirement
for cognate TCR recognition and nonspecifically activate CTLs. J. Immunol.
184: 3357–3366.
34. Hutchinson, S. L., L. Wooldridge, S. Tafuro, B. Laugel, M. Glick, J. M. Boulter,
B. K. Jakobsen, D. A. Price, and A. K. Sewell. 2003. The CD8 T cell coreceptor
exhibits disproportionate biological activity at extremely low binding affinities.
J. Biol. Chem. 278: 24285–24293.
35. Van Laethem, F., S. D. Sarafova, J. H. Park, X. Tai, L. Pobezinsky, T. I. Guinter,
S. Adoro, A. Adams, S. O. Sharrow, L. Feigenbaum, and A. Singer. 2007. Deletion
of CD4 and CD8 coreceptors permits generation of alphabetaT cells that
recognize antigens independently of the MHC. Immunity 27: 735–750.
36. Bosselut, R., T. I. Guinter, S. O. Sharrow, and A. Singer. 2003. Unraveling
a revealing paradox: why major histocompatibility complex I-signaled thymocytes
“paradoxically” appear as CD4+8lo transitional cells during positive selection
of CD8+ T cells. J. Exp. Med. 197: 1709–1719.
37. Maile, R., C. A. Siler, S. E. Kerry, K. E. Midkiff, E. J. Collins, and
J. A. Frelinger. 2005. Peripheral “CD8 tuning” dynamically modulates the size
and responsiveness of an antigen-specific T cell pool in vivo. J. Immunol. 174:
619–627.
38. Gangadharan, D., and H. Cheroutre. 2004. The CD8 isoform CD8alphaalpha is
not a functional homologue of the TCR co-receptor CD8alphabeta. Curr. Opin.
Immunol. 16: 264–270. 39. Daniels, M. A., L. Devine, J. D. Miller, J. M. Moser, A. E. Lukacher,
J. D. Altman, P. Kavathas, K. A. Hogquist, and S. C. Jameson. 2001. CD8
binding to MHC class I molecules is influenced by T cell maturation and glycosylation.
Immunity 15: 1051–1061.
40. Moody, A. M., D. Chui, P. A. Reche, J. J. Priatel, J. D. Marth, and
E. L. Reinherz. 2001. Developmentally regulated glycosylation of the CD8alphabeta
coreceptor stalk modulates ligand binding. Cell 107: 501–512.
41. Daniels, M. A., K. A. Hogquist, and S. C. Jameson. 2002. Sweet ‘n’ sour: the
impact of differential glycosylation on T cell responses. Nat. Immunol. 3: 903–
910.
42. Park, J. H., S. Adoro, P. J. Lucas, S. D. Sarafova, A. S. Alag, L. L. Doan,
B. Erman, X. Liu, W. Ellmeier, R. Bosselut, et al. 2007. ‘Coreceptor tuning’:
cytokine signals transcriptionally tailor CD8 coreceptor expression to the selfspecificity
of the TCR. Nat. Immunol. 8: 1049–1059. |
Tools
Tools
